Hydrogen has been shown to have antioxidant, anti-inflammatory, hormone-regulating, and apoptosis-resistance properties, among others. Based on a review of the research, the use of hydrogen might reduce the destructive cytokine storm and lung injury caused by SARS-CoV-2 during COVID-19 (Corona Virus Disease 2019) in the early stage, stimulating ropy sputum drainage, and ultimately reducing the incidence of severe disease. Molecular hydrogen treatment has the potential to become a new adjuvant therapy for COVID-19, but its efficacy and safety require large clinical trials and further confirmation.
CITATION STYLE
Yang, F., Yue, R., Luo, X., Liu, R., & Huang, X. (2020). Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients. Frontiers in Pharmacology, 11. https://doi.org/10.3389/fphar.2020.543718
Mendeley helps you to discover research relevant for your work.